- Four iPSC production platforms (ESTeam, I-Stem, PrimaStem, SAFE-IPS)
- Four tissue bioengineering platforms (ESTeam, I-Stem, IGBMC, SAFE-IPS)
- Two high-throughput screening platforms (I-Stem, IGBMC)
- One transgenic platform (PrimaStem)
- Two production platforms of future Advanced-Therapy Medicinal Products (ATMPs) for clinical trials phase I-II (ESTeam, I-Stem)
All of these platforms work in a coordinated manner according to their expertise and the organizational scheme as below.